2,3-Dichlorophenylpiperazine
From Wikipedia, the free encyclopedia
(Redirected from Dichlorophenylpiperazine)
This article is about the chemical compound. For the Disease Control Priorities Project, see Disease Control Priorities Project. For the New Jersey child protection agency now called the Division of Child Protection and Permanency, see Division of Youth and Family Services.
| Names | |
|---|---|
| IUPAC name
1-(2,3-dichlorophenyl)piperazine
|
|
| Identifiers | |
| 41202-77-1 |
|
| ChemSpider | 744460 |
| Jmol 3D image | Interactive graph |
| PubChem | 851833 |
|
|
|
|
| Properties | |
| C10H12Cl2N2 | |
| Molar mass | 231.12 g/mol |
| Appearance | brown oil |
| Density | 1.272g/cm3 °C |
| Melting point | 242 to 244 °C (468 to 471 °F; 515 to 517 K) |
| Boiling point | 365.1 °C (689.2 °F; 638.2 K) at 760mmHg |
| Hazards | |
| Flash point | 174.6 °C (346.3 °F; 447.8 K) |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
| Infobox references | |
2,3-Dichlorophenylpiperazine (2,3-DCPP or DCPP) is a chemical compound. It is both a precursor in the synthesis of aripiprazole and one of its metabolites.[1][2] It is unknown whether 2,3-DCPP is pharmacologically active similar to its close analogue 3-chlorophenylpiperazine (mCPP).
Chemical derivatives[edit]
See also[edit]
References[edit]
- ^ Leś A, Badowska-Rosłonek K, Łaszcz M, Kamieńska-Duda A, Baran P, Kaczmarek Ł (2010). "Optimization of aripiprazole synthesis". Acta Poloniae Pharmaceutica 67 (2): 151–7. PMID 20369792.
- ^ Caccia S (August 2007). "N-dealkylation of arylpiperazine derivatives: disposition and metabolism of the 1-aryl-piperazines formed". Current Drug Metabolism 8 (6): 612–22. doi:10.2174/138920007781368908. PMID 17691920.
| This article about an organic compound is a stub. You can help Wikipedia by expanding it. |

